Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings

Psyched Wellness Announces Private Placement for Proceeds of up to C$1,719,306.94

By The Northwire Desk — AI Analysis Mar 11, 2026 · 08:55 PSYC · 0.015 Psyched Wellness Ltd.
PSYC · Price

Executive Summary

  • Psyched Wellness entered a non‑binding term sheet with Gotham Green Fund III for a private placement of up to C$1.72 million in common shares and warrants, to be completed in two tranches.
  • The offering price is C$0.0101 per share and C$0.005 per warrant; each warrant allows purchase of an additional share at C$0.0051 for 60 months.
  • The company will also settle US$450,000 (≈C$615,780) debt to Zerkalo, LLC by issuing ~61 million common shares at a deemed price of C$0.0101 per share.

Key Details

  • Total Gross Proceeds: Up to C$1,719,306.94 in two tranches (each up to C$859,653.47).
  • Tranche 1 Closing Date: Expected around March 18 2026 for C$859,653.47.
  • Share Price: C$0.0101 per common share.
  • Warrant Terms: Priced at C$0.005 each; each warrant convertible into one additional share at C$0.0051 any time within 60 months from closing.
  • Holding Period: All securities subject to a four‑month and one‑day hold period from issuance.
  • Investor Rights Agreement:
  • One current independent director will resign at Tranche 1 close.
  • Investor Group may nominate two directors and two additional independent directors, keeping the board at ≤7 members with a majority independent.
  • Investor Group receives an 18‑month right of first refusal on future equity, debt, or convertible financings (excluding compensation plans).
  • Related Party Transaction: Classified as “related party” under MI 61‑101; exemptions applied because consideration < C$2.5 M and no shareholder approval required.
  • Debt Settlement with Zerkalo:
  • US$450,000 (≈C$615,780) debt settled by issuing 60,968,317 common shares at C$0.0101 per share.
  • Shares subject to the same four‑month and one‑day hold period.
  • Use of Proceeds: Net proceeds earmarked for working capital and other purposes permitted under CSE policies.
  • Regulatory Approvals: Subject to customary closing conditions, including approval by the Canadian Securities Exchange (CSE).

Notable Quotes

  • “The Offering is in the best interests of the Company and reasonable based on our current financial circumstances,” – Jeffrey Stevens, CEO.
Read the original news release →

More from Psyched Wellness Ltd.

Jun 10, 2026 · 17:16

Cash-burning micro‑cap supplement company faces leadership vacuum after CEO exit, with no safe‑harbor in sight.

Management Apr 23, 2026 · 07:31

Policy Tailwinds Mask Lingering FDA Safety Overhangs in Psyched Wellness

Other Mar 20, 2026 · 09:17

Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director

Financings Jan 15, 2026 · 12:43

Psyched Wellness Sells Out of First Run of Calmer and Announces New Production Run

Other